Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by NPISH Financing Schemes
This key economic indicator for the Healthcare sector has been recently updated.
- Poland was up 50% of Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by NPISH Financing Schemes in 2019, compared to a year earlier.
- Since 2014 Iceland Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by NPISH Financing Schemes rose 12.4% year on year to €32 Per Capita.
- In 2019 Poland was ranked number 3 in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by NPISH Financing Schemes.
- In 2019 Switzerland was ranked number 4 in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by NPISH Financing Schemes totalising €0.07 Per Capita, from 6 in 2018.
Top Countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by NPISH Financing Schemes
# | 8 Countries | Euros Per Capita | Last | YoY | 5‑years CAGR | |
---|---|---|---|---|---|---|
1 |
#1
Iceland
|
32.00 | 2019 | +3.8 % | +12.4 % | View data |
2 |
#2
Estonia
|
1.76 | 2019 | -7.8 % | NA | View data |
3 |
#3
Poland
|
0.27 | 2019 | +50.0 % | +0.8 % | View data |
4 |
#4
Portugal
|
0.07 | 2019 | +0.0 % | NA | View data |
4 |
#4
Switzerland
|
0.07 | 2019 | +16.7 % | -23.1 % | View data |
6 |
#6
Latvia
|
0.01 | 2018 | -95.7 % | NA | View data |
6 |
#6
Romania
|
0.01 | 2019 | NA | -39.2 % | View data |
8 |
#8
Croatia
|
0.00 | 2019 | NA | NA | View data |
Source: European Commission